Effect of propofol on endogenous morphine in serum


1Muhammad Rafiq, PhD1,2, Laure Pain
2Institute of Clinical Psychology, University of Management and Technology, Lahore (Pakistan)

CNRS, Unit UPR-3212, Neurobiology of Rhythms, University of Strasbourg, Strasbourg, (France)

Correspondence: Dr Muhammad Rafiq, Institute of Clinical Psychology, University of Management and Technology, C-II, Johar Town, Lahore (Pakistan)

E-mail: rafiqdar@hotmail.com; muhammad.rafiq@umt.edu.pk

ABSTRACT

Background & Objective: Studies have indicated that there is alteration of endogenous morphine after surgical interventions. As surgical interventions either clinical or experimental are carried out under anaesthesia. So, it cannot be concluded that the altered endogenous morphine is due to only surgical trauma. The research was, is there any anaesthetic effect on the endogenous morphine?
Objective of the current study was to determine any effect of propofol anaesthesia on the endogenous morphine.
Methodology: Young male rats were injected either propofol anesthesia or intralipid control and scarified at day 1 and      day 3 to obtain blood and serum samples. Endogenous morphine was quantified in the samples by using a morphine specific enzyme-linked immunosorbent assay kit. Results: one way ANVOA showed a significant effect of treatment at day 1 between propofol and intralipidic control (p < 0.05). There was also significant effect of propofol between days of treatment with propofol (p < 0.05) but not with intralipid controls (p < 0.05).
Conclusion: The current study showed that propofol anaesthesia increases the level of endogenous morphine at day 1 of the treatment. This increase of endogenous morphine till day 1 might show a protective effect as analgesic in reaction to propofol injection. However, this effect was diminished at day 3 of the treatment.
Key words: Endogenous morphine; Propofol; Anaesthesia; Circadian rhythms; Intralipid
Citation: Rafiq M. Effect of propofol on endogenous morphine in serum. Anaesth Pain & Intensive Care 2018;22(4):452-455
Received: 25 August 2018, Reviewed: 29 September, 23 October 2018, Corrected: 26 October 2018, Reviewed: 27 October 2018, Accepted: 01 November 2018

INTRODUCTION

            It has been believed that the synthesis of morphine is only limited to plants. However,       for the first time in 1985, it was evidenced that morphine is also found in animals and it was found in toad’s skin.1 Later on, endogenous morphine was isolated in many different           mammalian tissues including brain, liver, skin, adrenal gland and body fluids as well.2          Further, receptors for endogenous morphine were isolated and interestingly, these    receptors were observed in immune cells including human granulocytes and agranulocytes.3 On the basis of such studies, it may be proposed that there might exist a relationship between endogenous morphine and inflammatory process and the substances which are responsible in alteration of inflammatory processes. Studies have also proposed that       endogenous morphine is responsible in down-regulation of immune response to             inflammation and tissue injury.4
Postoperative state is the best condition to understand the process of inflammatory and     immune response. Reviews on clinical and experimental studies have indicated that     surgical procedures are associated with immune reactions in the form of innate and     acquired immunity. It has also been evidenced that the severity of immune reaction is        positively correlated with the extent of surgical procedure and other factors including type           of procedure or treatment given etc.5 It has also been demonstrated that endogenous morphine levels are increased after cardiac surgery and it is assumed that this increase may           be due to the inflammatory reaction caused by the cardiac surgery.6 Inflammation and          sepsis is also associated with surgical procedures and level of endogenous morphine has       also been observed to be increased in serum of such patients.7 However, this increase in         endogenous morphine may also be due to some other factors including any synergistic effect of anesthesia, circadian effect etc.

Usually, surgical procedures are associated with anesthesia and it cannot be assumed         that only inflammatory reactions are responsible for increase of endogenous morphine but    there may be a direct effect of anesthetics. So, we conducted the current study to   investigate any anesthetic effect on the endogenous morphine.
METHODOLOGY

Animals; Young male Sprague dawley rats were housed for fifteen days to acclimatize in a temperature of 24 ± 1 ºC and humidity (60 ± 10%) on 12/12/ light/dark period. The animals were provided ad libitum access to food and water.

Treatment; the subjects were allocated into two groups and sixteen subjects were included in each group. Subjects of Group 1 were injected with 120 mg/kg propofol (Fresenius, France) and subjects of Group 2 were injected with same dose of intralipid (Fresenius, France).

Procedure; all the injections were given at Zeitgeber Time 10 (ZT10), ten hours after light on and the subjects were sacrificed after euthanasia under CO2 at day 1 and day 3 at ZT5 (five hours after light on). Blood was collected, serum samples were prepared and stored at -20 ºC. A morphine specific enzyme-linked immunosorbent assay kit (Immunalysis Corporation, USA) was used to quantify the amount of endogenous morphine. For all the samples, endogenous morphine standards were used and coefficient of variance (CV) were less than 8%. Any sample with a CV more than 8% was retested to obtain appropriate CV.

RESULTS

One way ANOVA showed a significant effect between treatments: propofol and intralipid control when subjects were sacrificed at day 1 (F (1, 11) = 85.66, p = 0.001. There was also a significant effect of the day (between day 1 and day 3) of treatment with propofol determined by one way ANOVA (F (1, 10) = 7.034, p = 0.02. However, there was no significant effect of the day of treatment with intralipid determined by one way ANOVA (F (1, 10) =.739, p = 0.41. Results are shown in Figure 1.

8-OA-F1

Figure 1: Endogenous morphine (ng/ml) in rats’ serum after propofol anesthesia  (* p < 0.05).
DISCUSSION

            The current study investigated that there is significant effect of short duration anesthesia propofol on endogenous morphine when subjects were sacrificed a day after the treatment.       There was also significant effect of the day of treatment with propofol. However, there         was no effect of intralipid either given at day 1 or day 3. For the quantification of         endogenous morphine, Sprague Dawley rats were used, as these rodents have been shown              to have endogenous morphine in the blood samples.8 The levels of endogenous morphine were             quantified by using enzyme-linked immunosorbent assay, as this technique is useful for     the quantification of secondary metabolites like morphine.9
The subjects were sacrificed   at ZT5 to synchronize the experiments, as different proteins             show circadian variation during 24 hours of the day. However, no circadian variation      of endogenous morphine is studied yet, although endogenous morphine down regulates            different proteins and such proteins show circadian variations.10 Subjects received         intralipid as controls to avoid any bias of lipid effect11, as propofol anesthesia is lipophilic and is in lipidic solution.

The current study highlights for the first time the effect of any anesthetic on endogenous morphine which was also being used as anesthetic and analgesic. Propofol showed an effect            on endogenous morphine that is increased at day 1. This might be due to the fact that as       propofol injections are locally painful,12 the pain may trigger the endogenous           morphine release as a reaction to provide analgesic effect. This effect might continue             for around 48 hours, as on the day 3, endogenous morphine was observed to be equal to that in intralipid controls. This may be due to any circadian effect, as different anesthetic effects have been observed at different times of the day13 and it needs to be investigated further.     Whatever the reason of the increase of the endogenous morphine, it may have protective        effects, as opioid induced cardioprotection has been observed against myocardial      infarction.14 A recent study showed cardiac protection by suppressing proteasome             degradation of caveolin-3 in ischemic rodents.15 For anesthesiologists, the use of    propofol may be more protective as it gives synergistic effect by increasing endogenous     morphine. Especially, this may enhance the use of propofol anesthesia with cardiac    procedures and off course, further studies are needed to be conducted.

LIMITATIONS

Few limitations of the study: this increase of the endogenous morphine is limited to only short term propofol anesthesia and in young rats at zeitgeber time 5. Two questions remain to be answered; whether the results of this and similar studies can be applied to human beings and whether control of injection pain with propofol will have a dampening effect on the level of released endogenous morphine.

CONCLUSION

We conclude that there is a positive effect of propofol anesthesia in increasing endogenous morphine levels, and it might be implicated in cardioprotection and a possible chrono-therapeutic effect which should be considered for further studies.  However, this may be limited to short duration anesthesia and or only propofol anesthesia at ZT5. So, this may not predict any effect of long duration anesthetics and/ or other zeitgeber times.

Compliance with ethical standards

All the procedures were performed at Institute of Cellular and Integrative Neurosciences Strasbourg, France. Ethics on animal care used were followed in compliance with         Ministère de l'Agriculture et de la Forêt, Service Vétérinaire de la Santé et de la Protection Animale, France.

Conflict of interest
Authors declare that there is no conflict of interest for the current study.
Authors’  contribution:
MR-Concept, experiments, writing
LP-Concept, manuscript editing

REFERENCES

  1. Oka K, Kantrowitz JD, Spector S. Isolation of morphine from toad skin. Proc Natl Acad Sci U S A. 1985;82(6):1852-4. [PubMed]
  2. Donnerer J, Oka K, Brossi A, Rice KC, Spector S. Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci U S A. 1986;83(12):4566-7. [PubMed]
  3. Stefano GB, Scharrer B, Smith EM, Hughes Jr TK, Magazine HI, Bilfinger TV, et al. Opioid and opiate immunoregulatory processes. Crit Rev Immunol. 2017;37(2-6):213-48. [PubMed] DOI: 10.1615/CritRevImmunol.v37.i2-6.40
  4. Stefano GB, Scharrer B. Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol. 1994;4(2):57-67. [PubMed]
  5. Dąbrowska AM, Słotwiński R. The immune response to surgery and infection. Cent Eur J Immunol. 2014;39(4):532-7. [PubMed] DOI: 10.5114/ceji.2014.47741
  6. Brix-Christensen V, Tønnesen E, Sanchez RG, Bilfinger TV, Stefano GB. Endogenous morphine levels increase following cardiac surgery as part of the antiinflammatory response? Int J Cardiol. 1997;62(3):191-7. [PubMed]
  7. Glattard E, Welters ID, Lavaux T, Muller AH, Laux A, Zhang D, et al. Endogenous morphine levels are increased in sepsis: a partial implication of neutrophils. PLoS One. 2010;5(1):e8791. [PubMed] DOI: 10.1371/journal.pone.0008791
  8. Williams J, Haller VL, Stevens DL, Welch SP. Decreased basal endogenous opioid             levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception. Eur J Pharmacol. 2008;584(1):78-86. [PubMed] DOI: 10.1016/j.ejphar.2007.12.035
  9. Sakamoto S, Putalun W, Vimolmangkang S, Phoolcharoen W, Shoyama Y, Tanaka H, et al. Enzyme-linked immunosorbent assay for the quantitative/qualitative analysis of plant secondary metabolites. J Nat Med. 2018 ;72(1):32-42. [PubMed] DOI: 10.1007/s11418-017-1144-z
  10. Li L, Zhao GD, Shi Z, Qi LL, Zhou LY, Fu ZX. The Ras/Raf/MEK/ERK signaling pathway and its role in the occurrence and development of HCC. Oncol Lett. 2016;12(5):3045-50. [PubMed] DOI: 10.3892/ol.2016.5110
  11. Feng Y, Bai T, Ma H, Wang J-K. Propofol attenuates human proximal renal tubular epithelial cell injury induced by anoxia-reoxygenation. Laboratory Medicine. 2008;39(6):356-60. DOI: 10.1309/YVAD9JBUFGVGAAVP
  12. Desousa KA. Pain on propofol injection: causes and remedies. Indian J Pharmacol. 2016;48(6):617-23. [PubMed] DOI: 10.4103/0253-7613.194845
  13. Rafiq M, Ali S. Effect of Propofol on ERK1/2 expression during day times in the rat hippocampus. Adv Life Sci. 2018;5(3):130-4. [Free Full Text]
  14. Tanaka K, Kersten JR, Riess ML. Opioid-induced cardioprotection. Curr Pharm Des. 2014;20(36):5696-705. [PubMed]
  15. 15. Zhu A, Wei X, Zhang Y, You T, Yao S, Yuan S, et al. Propofol provides cardiac protection by suppressing the proteasome degradation of caveolin-3 in ischemic/reperfused rat hearts. J Cardiovasc Pharmacol. 2017;69(3):170-7. [PubMed] DOI: 10.1097/FJC.0000000000000454